Gossamer Bio regains Nasdaq minimum bid price compliance; deficiency closed

Gossamer Bio, Inc.

Received Nasdaq letter on March 4, 2024 confirming compliance with minimum bid price rule.
Common stock had failed to maintain $1.00 bid price for 30 consecutive days as of Oct 2023.
Nasdaq listing qualification matter is now closed.
Compliance regained with Nasdaq Global Select Market listing requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.